Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Basen Biotech is a high-tech enterprise specializing in the research, development, production, and sales of in vitro diagnostic (IVD) reagents and instruments. Founded in 2011 and headquartered in Guangzhou, China, the company focuses on point-of-care testing (POCT) solutions across various clinical areas, including infectious diseases, cardiovascular health, and chronic disease management. Their core technology platform utilizes Time-Resolved Fluorescence Immunoassay (TRFIA) to provide high-sensitivity and quantitative results for clinical diagnostics. Basen Biotech operates a large-scale manufacturing facility and maintains a robust distribution network serving both domestic and international markets. The company is recognized for its rapid response during the COVID-19 pandemic, providing various testing kits globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Basen.